Cargando…

Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses

Since Isaac's and Lindenmann's seminal experiments over 50 years ago demonstrating a soluble factor generated from heat killed virus-stimulated chicken embryos could inhibit live influenza virus replication, the term interferon has been synonymous with inhibition of virus replication. Whil...

Descripción completa

Detalles Bibliográficos
Autor principal: Teijaro, J.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112115/
https://www.ncbi.nlm.nih.gov/pubmed/27769506
http://dx.doi.org/10.1016/bs.ai.2016.08.001
_version_ 1783513421042417664
author Teijaro, J.R.
author_facet Teijaro, J.R.
author_sort Teijaro, J.R.
collection PubMed
description Since Isaac's and Lindenmann's seminal experiments over 50 years ago demonstrating a soluble factor generated from heat killed virus-stimulated chicken embryos could inhibit live influenza virus replication, the term interferon has been synonymous with inhibition of virus replication. While the antiviral properties of type 1 interferon (IFN-I) are undeniable, recent studies have reported expanding and somewhat unexpected roles of IFN-I signaling during both acute and persistent viral infections. IFN-I signaling can promote morbidity and mortality through induction of aberrant inflammatory responses and recruitment of inflammatory innate immune cell populations during acute respiratory viral infections. During persistent viral infection, IFN-I signaling promotes containment of early viral replication/dissemination, however, also initiates and maintains immune suppression, lymphoid tissue disorganization, and CD4 T cell dysfunction through modulation of multiple immune cell populations. Finally, new data are emerging illuminating how specific IFN-I species regulate immune pathology and suppression during acute and persistent viral infections, respectively. Systematic characterization of the cellular populations that produce IFN-I, how the timing of IFN-I induction and intricacies of subtype specific IFN-I signaling promote pathology or immune suppression during acute and persistent viral infections should inform the development of treatments and modalities to control viral associated pathologies.
format Online
Article
Text
id pubmed-7112115
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71121152020-04-02 Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses Teijaro, J.R. Adv Immunol Article Since Isaac's and Lindenmann's seminal experiments over 50 years ago demonstrating a soluble factor generated from heat killed virus-stimulated chicken embryos could inhibit live influenza virus replication, the term interferon has been synonymous with inhibition of virus replication. While the antiviral properties of type 1 interferon (IFN-I) are undeniable, recent studies have reported expanding and somewhat unexpected roles of IFN-I signaling during both acute and persistent viral infections. IFN-I signaling can promote morbidity and mortality through induction of aberrant inflammatory responses and recruitment of inflammatory innate immune cell populations during acute respiratory viral infections. During persistent viral infection, IFN-I signaling promotes containment of early viral replication/dissemination, however, also initiates and maintains immune suppression, lymphoid tissue disorganization, and CD4 T cell dysfunction through modulation of multiple immune cell populations. Finally, new data are emerging illuminating how specific IFN-I species regulate immune pathology and suppression during acute and persistent viral infections, respectively. Systematic characterization of the cellular populations that produce IFN-I, how the timing of IFN-I induction and intricacies of subtype specific IFN-I signaling promote pathology or immune suppression during acute and persistent viral infections should inform the development of treatments and modalities to control viral associated pathologies. Elsevier Inc. 2016 2016-09-20 /pmc/articles/PMC7112115/ /pubmed/27769506 http://dx.doi.org/10.1016/bs.ai.2016.08.001 Text en Copyright © 2016 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Teijaro, J.R.
Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
title Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
title_full Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
title_fullStr Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
title_full_unstemmed Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
title_short Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
title_sort pleiotropic roles of type 1 interferons in antiviral immune responses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112115/
https://www.ncbi.nlm.nih.gov/pubmed/27769506
http://dx.doi.org/10.1016/bs.ai.2016.08.001
work_keys_str_mv AT teijarojr pleiotropicrolesoftype1interferonsinantiviralimmuneresponses